Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Profit After Tax: 2016-2025

Historic Profit After Tax for Rhythm Pharmaceuticals (RYTM) over the last 5 years, with Sep 2025 value amounting to -$52.9 million.

  • Rhythm Pharmaceuticals' Profit After Tax fell 21.23% to -$52.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$192.3 million, marking a year-over-year increase of 25.72%. This contributed to the annual value of -$260.6 million for FY2024, which is 41.11% down from last year.
  • Per Rhythm Pharmaceuticals' latest filing, its Profit After Tax stood at -$52.9 million for Q3 2025, which was down 13.45% from -$46.6 million recorded in Q2 2025.
  • In the past 5 years, Rhythm Pharmaceuticals' Profit After Tax ranged from a high of $65.8 million in Q1 2021 and a low of -$141.4 million during Q1 2024.
  • For the 3-year period, Rhythm Pharmaceuticals' Profit After Tax averaged around -$54.0 million, with its median value being -$46.6 million (2025).
  • Per our database at Business Quant, Rhythm Pharmaceuticals' Profit After Tax surged by 292.47% in 2021 and then tumbled by 180.24% in 2022.
  • Quarterly analysis of 5 years shows Rhythm Pharmaceuticals' Profit After Tax stood at -$42.9 million in 2021, then climbed by 0.87% to -$42.5 million in 2022, then grew by 2.02% to -$41.6 million in 2023, then fell by 3.98% to -$43.3 million in 2024, then declined by 21.23% to -$52.9 million in 2025.
  • Its Profit After Tax was -$52.9 million in Q3 2025, compared to -$46.6 million in Q2 2025 and -$49.5 million in Q1 2025.